Financing

Transave has completed the following financings:

• $4 million Series A Financing in August 2000 led by TVM Capital.
• $14 million Series B Financing in December 2002 led by TVM Capital, Forbion Capital Partners and Easton Hunt Capital Partners.
• $40 million Series C Financing in February 2006 led by Prospect Venture Partners and Fidelity Biosciences. Additional investments were made by TVM Capital, Forbion Capital Partners and Easton Hunt Capital Partners.
• $35 million Series D Financing in March 2008 led by Quaker BioVentures and Bessemer Venture Partners. Additional investments were made by TVM Capital, Prospect Venture Partners, Fidelity Biosciences, Forbion Capital Partners and Easton Hunt Capital Partners.
• $12.5 million Venture Loan in August 2008 from CIT Healthcare and Compass Horizon Funding Company, part of Horizon Technology Finance LLC.

Transave has recently closed a $35 million Series D private equity financing.